Endeavor

Cell Therapy Changed Cancer Care. Now Researchers Want to Make It Work Better

Moffitt brought together experts from across the country to explore ways to make cell therapies more durable and effective for more patients

Inside the Breakthroughs That Changed Melanoma Care

Moffitt researchers helped drive decades of FDA approvals that transformed patient outcomes

Immunotherapy Pioneer Steven Rosenberg Reflects on Past Breakthroughs and Future Promise

Legendary researcher connects immunotherapy’s origins to its future at Moffitt

Can Hybrid Immunotherapy Improve Solid Tumor Treatment?

Moffitt researchers test CAR-TIL cells combining tumor navigation and targeted attack

Moffitt Launches Immunotherapy Podcast

Monthly series highlights visionaries in immunotherapy and the breakthroughs that are transforming lives

Moffitt Study Shows New Immune Boost Could Expand Access to Cancer Immunotherapy

Adding a natural protein improves the speed and success of TIL manufacturing, potentially benefiting more patients

Moffitt Experts’ Study Aims to Improve TIL Therapy Process

Tumor-infiltrating lymphocyte therapy is FDA approved to treat melanoma.

TIL Therapy for Advanced Melanoma Offers Promising Results

The study shows 36% of patients experienced a positive response to the therapy

Moffitt Experts Share Discoveries Driving Innovation in Cancer Immunotherapy

The Society for Immunotherapy of Cancer brings together industry leaders to highlight new research and clinical applications in immunotherapy